Hydrops Fetalis Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Thalassemia, specifically alpha thalassemia, is one cause and hemolytic disease is another. The pediatric hematologists at Dana-Farber/Boston Children's Hospital are experts in the genetic evaluation of families at risk for both immune and non-immune hydrops due to severe fetal anemia.

For more information about current research, visit www.danafarberbostonchildrens.org.

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close